reduced, as of 08:06, 23 March 2023 (UTC)
Side by side comparison
{{Infobox drug}}{{Infobox drug/sandbox}}
Infobox drug/testcases-FDA
Clinical data
Trade namesBayer Aspirin, others
Other names
  • 2-acetoxybenzoic acid
  • o-acetylsalicylic acid
  • acetylsalicylic acid
  • acetyl salicylate
AHFS/Drugs.comMonograph
MedlinePlusa682878
License data
Pregnancy
category
ATC code
Legal status
Legal status
Identifiers
  • 2-acetyloxybenzoic acid[4]
CAS Number
PubChem CID
IUPHAR/BPS
DrugBank
ChemSpider
UNII
KEGG
ChEBI
ChEMBL
PDB ligand
Chemical and physical data
FormulaC9H8O4
Molar mass180.16 g·mol−1
Infobox drug/testcases-FDA
Clinical data
Trade namesBayer Aspirin, others
Other names
  • 2-acetoxybenzoic acid
  • o-acetylsalicylic acid
  • acetylsalicylic acid
  • acetyl salicylate
AHFS/Drugs.comMonograph
MedlinePlusa682878
License data
Pregnancy
category
ATC code
Legal status
Legal status
Identifiers
  • 2-acetyloxybenzoic acid[4]
CAS Number
PubChem CID
IUPHAR/BPS
DrugBank
ChemSpider
UNII
KEGG
ChEBI
ChEMBL
PDB ligand
Chemical and physical data
FormulaC9H8O4
Molar mass180.16 g·mol−1
  • from article, ref name=b92:
Aspirin, an acetyl derivative of salicylic acid, is a white, crystalline, weakly acidic substance, which melts at 136 °C (277 °F),[5] :
/sandbox2
Clinical data
License data
../licence/sandbox
License data

aspirin (complete)

සංස්කරණය
as of 08:06, 23 March 2023 (UTC)
Side by side comparison
{{Infobox drug}}{{Infobox drug/sandbox}}
Infobox drug/testcases-FDA
Clinical data
Pronunciationacetylsalicylic acid /əˌstəlˌsælˈsɪlk/
Trade namesBayer Aspirin, others
Other names
  • 2-acetoxybenzoic acid
  • o-acetylsalicylic acid
  • acetylsalicylic acid
  • acetyl salicylate
AHFS/Drugs.comMonograph
MedlinePlusa682878
License data
Pregnancy
category
Routes of
administration
By mouth, rectal
ATC code
Legal status
Legal status
Pharmacokinetic data
Bioavailability80–100%[8]
Protein binding80–90%[9]
MetabolismLiver (CYP2C19 and possibly CYP3A), some is also hydrolysed to salicylate in the gut wall.[9]
Elimination half-lifeDose-dependent; 2–3 h for low doses (100 mg or less), 15–30 h for large doses.[9]
ExcretionUrine (80–100%), sweat, saliva, feces[8]
Identifiers
  • 2-acetyloxybenzoic acid[10]
CAS Number
PubChem CID
IUPHAR/BPS
DrugBank
ChemSpider
UNII
KEGG
ChEBI
ChEMBL
PDB ligand
Chemical and physical data
FormulaC9H8O4
Molar mass180.16 g·mol−1
3D model (JSmol)
Density1.40 g/cm3
Melting point136 °C (277 °F) [5]
Boiling point140 °C (284 °F) (decomposes)
Solubility in water3 g/L
  • O=C(C)Oc1ccccc1C(=O)O
  • InChI=1S/C9H8O4/c1-6(10)13-8-5-3-2-4-7(8)9(11)12/h2-5H,1H3,(H,11,12) YesY
  • Key:BSYNRYMUTXBXSQ-UHFFFAOYSA-N YesY
  (verify)
Infobox drug/testcases-FDA
Clinical data
Pronunciationacetylsalicylic acid /əˌstəlˌsælˈsɪlk/
Trade namesBayer Aspirin, others
Other names
  • 2-acetoxybenzoic acid
  • o-acetylsalicylic acid
  • acetylsalicylic acid
  • acetyl salicylate
AHFS/Drugs.comMonograph
MedlinePlusa682878
License data
Pregnancy
category
Routes of
administration
By mouth, rectal
ATC code
Legal status
Legal status
Pharmacokinetic data
Bioavailability80–100%[8]
Protein binding80–90%[9]
MetabolismLiver (CYP2C19 and possibly CYP3A), some is also hydrolysed to salicylate in the gut wall.[9]
Elimination half-lifeDose-dependent; 2–3 h for low doses (100 mg or less), 15–30 h for large doses.[9]
ExcretionUrine (80–100%), sweat, saliva, feces[8]
Identifiers
  • 2-acetyloxybenzoic acid[10]
CAS Number
PubChem CID
IUPHAR/BPS
DrugBank
ChemSpider
UNII
KEGG
ChEBI
ChEMBL
PDB ligand
Chemical and physical data
FormulaC9H8O4
Molar mass180.16 g·mol−1
3D model (JSmol)
Density1.40 g/cm3
Melting point136 °C (277 °F) [5]
Boiling point140 °C (284 °F) (decomposes)
Solubility in water3 g/L
  • O=C(C)Oc1ccccc1C(=O)O
  • InChI=1S/C9H8O4/c1-6(10)13-8-5-3-2-4-7(8)9(11)12/h2-5H,1H3,(H,11,12) YesY
  • Key:BSYNRYMUTXBXSQ-UHFFFAOYSA-N YesY
  (verify)
  • from article, ref name=b92:
Aspirin, an acetyl derivative of salicylic acid, is a white, crystalline, weakly acidic substance, which melts at 136 °C (277 °F),[5] :
  1. ^ a b "Aspirin Use During Pregnancy". Drugs.com. 2 April 2018. සම්ප්‍රවේශය 29 December 2019.
  2. ^ https://www.tga.gov.au/resources/publication/publications/otc-medicine-monograph-aspirin-tablets-oral-use
  3. ^ "Poisons Standard October 2022". Australian Government Federal Register of Legislation. සම්ප්‍රවේශය 9 January 2023.
  4. ^ CID 2244 from PubChem
  5. ^ a b c සැකිල්ල:RubberBible92nd
  6. ^ https://www.tga.gov.au/resources/publication/publications/otc-medicine-monograph-aspirin-tablets-oral-use
  7. ^ "Poisons Standard October 2022". Australian Government Federal Register of Legislation. සම්ප්‍රවේශය 9 January 2023.
  8. ^ a b "Zorprin, Bayer Buffered Aspirin (aspirin) dosing, indications, interactions, adverse effects, and more". Medscape Reference. WebMD. 7 April 2014 දින පැවති මුල් පිටපත වෙතින් සංරක්ෂිත පිටපත. සම්ප්‍රවේශය 3 April 2014.
  9. ^ a b c Brayfield A, ed. (14 January 2014). "Aspirin". Martindale: The Complete Drug Reference. Pharmaceutical Press. සම්ප්‍රවේශය 3 April 2014.
  10. ^ CID 2244 from PubChem
"https://si.wikipedia.org/w/index.php?title=සැකිල්ල:Infobox_drug/testcases-FDA&oldid=682085" වෙතින් සම්ප්‍රවේශනය කෙරිණි